Here are preliminary results of the bibliometric mapping of the 2022 Luxembourg research evaluation. Its purpose is:
The method for the research-field-mapping can be reviewed here:
Note: The analysis in this document depicts the larger research field around the department, thereby all analysis results are based on the publications of the department plus related
Note: The seed articles deemed representative for
the active areas of research in the institution, and include authors
affiliated with the institution. The departments research field is
identified by selecting the 2000 most similar publications to the
selected seed articles. See Technical descriptionfor
additional explanations.
| AU | PY | TI | JI |
|---|---|---|---|
| GONDER S;FERNANDEZ BOTANA I… | 2020 | METHOD FOR THE ANALYSIS OF THE TUMOR MICROENVIRONMENT BY MASS CYTOMETRY: APPLICATION TO CHRONIC L… | FRONT. IMMUNOL. |
| DITTMAR G;WINKLHOFER KF | 2020 | LINEAR UBIQUITIN CHAINS: CELLULAR FUNCTIONS AND STRATEGIES FOR DETECTION AND QUANTIFICATION | FRONT. CHEM. |
| SCHLICKER L;BOERS HM;DUDEK … | 2019 | POSTPRANDIALMETABOLIC EFFECTS OF FIBERMIXES REVEALED BY IN VIVO STABLE ISOTOPE LABELING IN HUMANS | METABOLITES |
| DUFRESNE J;BOWDEN P;THAVARA… | 2018 | THE PLASMA PEPTIDOME 03 CHEMICAL SCIENCES 0301 ANALYTICAL CHEMISTRY | CLIN. PROTEOMICS |
| HIPP G;VAILLANT M;DIEDERICH… | 2018 | THE LUXEMBOURG PARKINSON’S STUDY: A COMPREHENSIVE APPROACH FOR STRATIFICATION AND EARLY DIAGNOSIS | FRONT. AGING NEUROSCI. |
| BAHLAWANE C;SCHMITZ M;LETEL… | 2017 | INSIGHTS INTO LIGAND STIMULATION EFFECTS ON GASTRO-INTESTINAL STROMAL TUMORS SIGNALLING | CELL. SIGNAL. |
Note: This section provides basic descriptives of th
identified research fielld, including number of articles over time,
countries, institutions, and authors. See
Technical descriptionfor additional explanations.
Note: Here, we report the results of a LDA
topic-modelling (basically, clustering on words) on all title+abstract
texts. Identified topics can be interpreted as broad themes in the
research field. See Technical descriptionfor additional
explanations.
Note: While this static vies is helpful, I recommend using the interactive LDAVis version to be found under https://daniel-hain.github.io/biblio_lux_2022/output/topic_modelling/LDAviz_lih_tmoh.rds/index.html#topic=1&lambda=0.60&term=. For functionality and usage, see ´Technical ´.
Note: This analysis refers the co-citation analysis,
where the cited references and not the original publications are the
unit of analysis. Identified knowledge bases can be interpreted as the
knowledge foundation the field draws from. See
Technical descriptionfor additional explanations.
| name | dgr_int | dgr |
|---|---|---|
| Knowledge Base 1: KB 1: biology of protein ubiquitination (n = 2065, density =3.11) | ||
| KOMANDER D. RAPE M. THE UBIQUITIN CODE (2012) | 7134 | 8794 |
| SWATEK K.N. KOMANDER D. UBIQUITIN MODIFICATIONS (2016) | 3971 | 4552 |
| YAU R. RAPE M. THE INCREASING COMPLEXITY OF THE UBIQUITIN CODE (2016) | 3682 | 3974 |
| HERSHKO A. CIECHANOVER A. THE UBIQUITIN SYSTEM (1998) | 3557 | 4494 |
| MEYER H.J. RAPE M. ENHANCED PROTEIN DEGRADATION BY BRANCHED UBIQUITIN CHAINS (2014) | 2449 | 2517 |
| HUSNJAK K. DIKIC I. UBIQUITIN-BINDING PROTEINS: DECODERS OF UBIQUITIN-MEDIATED CELLULAR FUNCTIONS (2012) | 2269 | 2641 |
| MEVISSEN T.E.T. KOMANDER D. MECHANISMS OF DEUBIQUITINASE SPECIFICITY AND REGULATION (2017) | 2154 | 2487 |
| YE Y. RAPE M. BUILDING UBIQUITIN CHAINS: E2 ENZYMES AT WORK (2009) | 1305 | 1347 |
| DESHAIES R.J. JOAZEIRO C.A. RING DOMAIN E3 UBIQUITIN LIGASES (2009) | 1275 | 1410 |
| WENZEL D.M. LISSOUNOV A. BRZOVIC P.S. KLEVIT R.E. UBCH7 REACTIVITY PROFILE REVEALS PARKIN AND HHARI TO BE RING/HECT HYBRIDS (2011) | 1236 | 1584 |
| Knowledge Base 2: KB 2: research on Parkinson’s disease (n = 1308, density =2.52) | ||
| HUGHES A.J. DANIEL S.E. KILFORD L. LEES A.J. ACCURACY OF CLINICAL DIAGNOSIS OF IDIOPATHIC PARKINSON’S DISEASE: A CLINICO-PATHOLOGICAL STUDY OF 100 … | 2178 | 2178 |
| GILMAN S. WENNING G.K. LOW P.A. SECOND CONSENSUS STATEMENT ON THE DIAGNOSIS OF MULTIPLE SYSTEM ATROPHY (2008) | 1151 | 1151 |
| POSTUMA R.B. BERG D. STERN M. MDS CLINICAL DIAGNOSTIC CRITERIA FOR PARKINSON’S DISEASE (2015) | 963 | 963 |
| LITVAN I. AGID Y. CALNE D. CLINICAL RESEARCH CRITERIA FOR THE DIAGNOSIS OF PROGRESSIVE SUPRANUCLEAR PALSY (STEELE-RICHARDSON-OLSZEWSKI SYNDROME) | 930 | 930 |
| HOEHN M.M. YAHR M.D. PARKINSONISM: ONSET PROGRESSION AND MORTALITY (1967) | 891 | 891 |
| TOMLINSON C.L. STOWE R. PATEL S. RICK C. GRAY R. CLARKE C.E. SYSTEMATIC REVIEW OF LEVODOPA DOSE EQUIVALENCY REPORTING IN PARKINSON’S DISEASE (2010) | 777 | 777 |
| BERG D. POSTUMA R.B. ADLER C.H. MDS RESEARCH CRITERIA FOR PRODROMAL PARKINSON’S DISEASE (2015) | 656 | 656 |
| GOLBE L.I. OHMAN-STRICKLAND P.A. A CLINICAL RATING SCALE FOR PROGRESSIVE SUPRANUCLEAR PALSY (2007) | 642 | 642 |
| EMRE M. AARSLAND D. BROWN R. CLINICAL DIAGNOSTIC CRITERIA FOR DEMENTIA ASSOCIATED WITH PARKINSON’S DISEASE (2007) | 539 | 539 |
| HELY M.A. REID W.G. ADENA M.A. HALLIDAY G.M. MORRIS J.G. THE SYDNEY MULTICENTER STUDY OF PARKINSON’S DISEASE: THE INEVITABILITY OF DEMENTIA AT 20 Y… | 435 | 435 |
| Knowledge Base 3: KB 3: Single cell analysis (n = 921, density =6.27) | ||
| BRUGGNER R.V. BODENMILLER B. DILL D.L. TIBSHIRANI R.J. NOLAN G.P. AUTOMATED IDENTIFICATION OF STRATIFYING SIGNATURES IN CELLULAR SUBPOPULATIONS (2014) | 1491 | 1491 |
| VAN DER MAATEN L. HINTON G. VISUALIZING DATA USING T-SNE (2008) | 1155 | 1158 |
| WEBER L.M. ROBINSON M.D. COMPARISON OF CLUSTERING METHODS FOR HIGH-DIMENSIONAL SINGLE-CELL FLOW AND MASS CYTOMETRY DATA (2016) | 1093 | 1093 |
| SPITZER M.H. NOLAN G.P. MASS CYTOMETRY: SINGLE CELLS MANY FEATURES (2016) | 1026 | 1026 |
| LEVINE J.H. DATA-DRIVEN PHENOTYPIC DISSECTION OF AML REVEALS PROGENITOR-LIKE CELLS THAT CORRELATE WITH PROGNOSIS (2015) | 948 | 948 |
| SAMUSIK N. GOOD Z. SPITZER M.H. DAVIS K.L. NOLAN G.P. AUTOMATED MAPPING OF PHENOTYPE SPACE WITH SINGLE-CELL DATA (2016) | 888 | 888 |
| BENDALL S.C. NOLAN G.P. ROEDERER M. CHATTOPADHYAY P.K. A DEEP PROFILER’S GUIDE TO CYTOMETRY (2012) | 762 | 762 |
| BANDURA D.R. BARANOV V.I. ORNATSKY O.I. ANTONOV A. KINACH R. LOU X. PAVLOV S. TANNER S.D. MASS CYTOMETRY: TECHNIQUE FOR REAL TIME SINGLE CELL MULTI… | 748 | 748 |
| SHEKHAR K. BRODIN P. DAVIS M.M. CHAKRABORTY A.K. AUTOMATIC CLASSIFICATION OF CELLULAR EXPRESSION BY NONLINEAR STOCHASTIC EMBEDDING (ACCENSE) | 698 | 698 |
| KOTECHA N. KRUTZIK P.O. IRISH J.M. WEB-BASED ANALYSIS AND PUBLICATION OF FLOW CYTOMETRY EXPERIMENTS (2010) | 679 | 679 |
| Knowledge Base 4: KB 4: impact of ubiquitination on TNF signaling (n = 728, density =12.89) | ||
| MICHEAU O. TSCHOPP J. INDUCTION OF TNF RECEPTOR I-MEDIATED APOPTOSIS VIA TWO SEQUENTIAL SIGNALING COMPLEXES (2003) | 1353 | 2007 |
| HAAS T.L. EMMERICH C.H. GERLACH B. SCHMUKLE A.C. CORDIER S.M. RIESER E. FELTHAM R. WENGER T. RECRUITMENT OF THE LINEAR UBIQUITIN CHAIN ASSEMBLY COM… | 1251 | 1384 |
| KIRISAKO T. KAMEI K. MURATA S. KATO M. FUKUMOTO H. KANIE M. SANO S. IWAI K. A UBIQUITIN LIGASE COMPLEX ASSEMBLES LINEAR POLYUBIQUITIN CHAINS (2006) | 1212 | 1738 |
| DRABER P. KUPKA S. REICHERT M. DRABEROVA H. LAFONT E. DE MIGUEL D. SPILGIES L. HARTWIG T. LUBAC-RECRUITED CYLD AND A20 REGULATE GENE ACTIVATION AND… | 1055 | 1130 |
| GERLACH B. CORDIER S.M. SCHMUKLE A.C. EMMERICH C.H. RIESER E. HAAS T.L. WEBB A.I. WONG W.W. LINEAR UBIQUITINATION PREVENTS INFLAMMATION AND REGULAT… | 990 | 1090 |
| BERTRAND M.J. MILUTINOVIC S. DICKSON K.M. HO W.C. BOUDREAULT A. DURKIN J. GILLARD J.W. BARKER P.A. CIAP1 AND CIAP2 FACILITATE CANCER CELL SURVIVAL … | 972 | 999 |
| HE S. WANG L. MIAO L. WANG T. DU F. ZHAO L. WANG X. RECEPTOR INTERACTING PROTEIN KINASE-3 DETERMINES CELLULAR NECROTIC RESPONSE TO TNF-ALPHA (2009) | 972 | 989 |
| OBERST A. DILLON C.P. WEINLICH R. MCCORMICK L.L. FITZGERALD P. POP C. HAKEM R. GREEN D.R. CATALYTIC ACTIVITY OF THE CASPASE-8-FLIP(L) | 819 | 834 |
| PELTZER N. RIESER E. TARABORRELLI L. DRABER P. DARDING M. PERNAUTE B. SHIMIZU Y. MONTINARO A. HOIP DEFICIENCY CAUSES EMBRYONIC LETHALITY BY ABERRAN… | 751 | 786 |
| WANG L. DU F. WANG X. TNF-ALPHA INDUCES TWO DISTINCT CASPASE-8 ACTIVATION PATHWAYS (2008) | 721 | 1069 |
| Knowledge Base 5: KB 5: study of gastointestinal cancer (n = 666, density =12.62) | ||
| MIETTINEN M. LASOTA J. GASTROINTESTINAL STROMAL TUMORS: PATHOLOGY AND PROGNOSIS AT DIFFERENT SITES (2006) | 1351 | 1351 |
| HIROTA S. ISOZAKI K. MORIYAMA Y. GAIN-OF-FUNCTION MUTATIONS OF C-KIT IN HUMAN GASTROINTESTINAL STROMAL TUMORS (1998) | 1285 | 1285 |
| VERWEIJ J. CASALI P.G. ZALCBERG J. PROGRESSION-FREE SURVIVAL IN GASTROINTESTINAL STROMAL TUMOURS WITH HIGH-DOSE IMATINIB: RANDOMISED TRIAL (2004) | 1116 | 1116 |
| HEINRICH M.C. CORLESS C.L. DUENSING A. PDGFRA ACTIVATING MUTATIONS IN GASTROINTESTINAL STROMAL TUMORS (2003) | 1070 | 1070 |
| DEMETRI G.D. VON MEHREN M. BLANKE C.D. EFFICACY AND SAFETY OF IMATINIB MESYLATE IN ADVANCED GASTROINTESTINAL STROMAL TUMORS (2002) | 1053 | 1053 |
| DEMETRI G.D. VAN OOSTEROM A.T. GARRETT C.R. EFFICACY AND SAFETY OF SUNITINIB IN PATIENTS WITH ADVANCED GASTROINTESTINAL STROMAL TUMOUR AFTER FAILUR… | 907 | 907 |
| BLANKE C.D. RANKIN C. DEMETRI G.D. PHASE III RANDOMIZED INTERGROUP TRIAL ASSESSING IMATINIB MESYLATE AT TWO DOSE LEVELS IN PATIENTS WITH UNRESECTAB… | 806 | 806 |
| HEINRICH M.C. CORLESS C.L. DEMETRI G.D. KINASE MUTATIONS AND IMATINIB RESPONSE IN PATIENTS WITH METASTATIC GASTROINTESTINAL STROMAL TUMOR (2003) | 739 | 739 |
| CORLESS C.L. BARNETT C.M. HEINRICH M.C. GASTROINTESTINAL STROMAL TUMOURS: ORIGIN AND MOLECULAR ONCOLOGY (2011) | 737 | 737 |
| JOENSUU H. RISK STRATIFICATION OF PATIENTS DIAGNOSED WITH GASTROINTESTINAL STROMAL TUMOR (2008) | 723 | 723 |
| Knowledge Base 6: KB 6: role of ubiquitination in immunity (n = 469, density =21.68) | ||
| GERLACH B. CORDIER S.M. SCHMUKLE A.C. EMMERICH C.H. RIESER E. HAAS T.L. LINEAR UBIQUITINATION PREVENTS INFLAMMATION AND REGULATES IMMUNE SIGNALLING… | 1422 | 1744 |
| HAAS T.L. EMMERICH C.H. GERLACH B. SCHMUKLE A.C. CORDIER S.M. RIESER E. RECRUITMENT OF THE LINEAR UBIQUITIN CHAIN ASSEMBLY COMPLEX STABILIZES THE T… | 1111 | 1344 |
| BOISSON B. LAPLANTINE E. DOBBS K. COBAT A. TARANTINO N. HAZEN M. HUMAN HOIP AND LUBAC DEFICIENCY UNDERLIES AUTOINFLAMMATION IMMUNODEFICIENCY AMYLOP… | 931 | 1072 |
| DRABER P. KUPKA S. REICHERT M. DRABEROVA H. LAFONT E. DE MIGUEL D. LUBAC-RECRUITED CYLD AND A20 REGULATE GENE ACTIVATION AND CELL DEATH BY EXERTING… | 890 | 1062 |
| BOISSON B. LAPLANTINE E. PRANDO C. GILIANI S. ISRAELSSON E. XU Z. IMMUNODEFICIENCY AUTOINFLAMMATION AND AMYLOPECTINOSIS IN HUMANS WITH INHERITED HO… | 880 | 998 |
| DAMGAARD R.B. WALKER J.A. MARCO-CASANOVA P. MORGAN N.V. TITHERADGE H.L. ELLIOTT P.R. THE DEUBIQUITINASE OTULIN IS AN ESSENTIAL NEGATIVE REGULATOR O… | 839 | 994 |
| ELLIOTT P.R. LESKE D. HRDINKA M. BAGOLA K. FIIL B.K. MCLAUGHLIN S.H. SPATA2 LINKS CYLD TO LUBAC ACTIVATES CYLD AND CONTROLS LUBAC SIGNALING (2016) | 766 | 910 |
| KEUSEKOTTEN K. ELLIOTT P.R. GLOCKNER L. FIIL B.K. DAMGAARD R.B. KULATHU Y. OTULIN ANTAGONIZES LUBAC SIGNALING BY SPECIFICALLY HYDROLYZING MET1-LINK… | 691 | 971 |
| FIIL B.K. DAMGAARD R.B. WAGNER S.A. KEUSEKOTTEN K. FRITSCH M. BEKKER-JENSEN S. OTULIN RESTRICTS MET1-LINKED UBIQUITINATION TO CONTROL INNATE IMMUNE… | 686 | 811 |
| KUPKA S. DE MIGUEL D. DRABER P. MARTINO L. SURINOVA S. RITTINGER K. SPATA2-MEDIATED BINDING OF CYLD TO HOIP ENABLES CYLD RECRUITMENT TO SIGNALING C… | 678 | 820 |
| Knowledge Base 7: KB 7: proteomics based on mass spectrometry (n = 402, density =11.88) | ||
| CRAIG R. BEAVIS R.C. TANDEM: MATCHING PROTEINS WITH TANDEM MASS SPECTRA (2004) | 1262 | 1262 |
| COX J. MANN M. MAXQUANT ENABLES HIGH PEPTIDE IDENTIFICATION RATES INDIVIDUALIZED P.P.B.-RANGE MASS ACCURACIES AND PROTEOME-WIDE PROTEIN QUANTIFICAT… | 699 | 1001 |
| ENG J.K. MCCORMACK A.L. YATES J.R. AN APPROACH TO CORRELATE TANDEM MASS SPECTRAL DATA OF PEPTIDES WITH AMINO ACID SEQUENCES IN A PROTEIN DATABASE (… | 420 | 439 |
| ELIAS J.E. GYGI S.P. TARGET-DECOY SEARCH STRATEGY FOR INCREASED CONFIDENCE IN LARGE-SCALE PROTEIN IDENTIFICATIONS BY MASS SPECTROMETRY (2007) | 347 | 374 |
| BOWDEN P. BEAVIS R. MARSHALL J. TANDEM MASS SPECTROMETRY OF HUMAN TRYPTIC BLOOD PEPTIDES CALCULATED BY A STATISTICAL ALGORITHM AND CAPTURED BY A RE… | 312 | 312 |
| SCHWARTZ J.C. SENKO M.W. SYKA J.E. A TWO-DIMENSIONAL QUADRUPOLE ION TRAP MASS SPECTROMETER (2002) | 304 | 304 |
| BENJAMINI Y. HOCHBERG Y. CONTROLLING FALSE DISCOVERY RATE: A PRACTICAL APPROACH TO MULTIPLE TESTING (1995) | 295 | 295 |
| BOWDEN P. META SEQUENCE ANALYSIS OF HUMAN BLOOD PEPTIDES AND THEIR PARENT PROTEINS (2010) | 294 | 294 |
| BOWDEN P. QUANTITATIVE STATISTICAL ANALYSIS OF STANDARD AND HUMAN BLOOD PROTEINS FROM LIQUID CHROMATOGRAPHY ELECTROSPRAY IONIZATION AND TANDEM MASS… | 294 | 294 |
| FLORENTINUS A.K. IDENTIFICATION AND QUANTIFICATION OF PEPTIDES AND PROTEINS SECRETED FROM PROSTATE EPITHELIAL CELLS BY UNBIASED LIQUID CHROMATOGRAP… | 294 | 294 |
Note: This analysis refers the bibliographic
coupling analysis, where original publications are the unit of analysis.
Identified research areas can be interpreted as the field’s current
research frontier. See Technical descriptionfor additional
explanations.
| AU | PY | TI | dgr_int | TC | TC_year |
|---|---|---|---|---|---|
| Research Area 1: RA 1: Parkinson’s disease research (n = 1178, density =0.14) | |||||
| GBD 2016 PARKINSON’S D… | 2018 | GLOBAL, REGIONAL, AND NATIONAL BURDEN OF PARKINSON’S DISEASE, 1990–2016: A SYSTEMATIC ANALYSIS FOR THE GLOBAL BURDEN OF DI… | 3.14 | 855 | 213.75 |
| ARMSTRONG MJ;OKUN MS | 2020 | DIAGNOSIS AND TREATMENT OF PARKINSON DISEASE: A REVIEW | 1.95 | 507 | 253.50 |
| POSTUMA RB;IRANZO A;HU… | 2019 | RISK AND PREDICTORS OF DEMENTIA AND PARKINSONISM IN IDIOPATHIC REM SLEEP BEHAVIOUR DISORDER: A MULTICENTRE STUDY | 2.63 | 313 | 104.33 |
| OBESO JA;STAMELOU M;GO… | 2017 | PAST, PRESENT, AND FUTURE OF PARKINSON’S DISEASE: A SPECIAL ESSAY ON THE 200TH ANNIVERSARY OF THE SHAKING PALSY | 2.26 | 363 | 72.60 |
| DUNCAN GW;FIRBANK MJ;Y… | 2016 | GRAY AND WHITE MATTER IMAGING: A BIOMARKER FOR COGNITIVE IMPAIRMENT IN EARLY PARKINSON’S DISEASE? | 6.16 | 98 | 16.33 |
| TYSNES O-B;STORSTEIN A | 2017 | EPIDEMIOLOGY OF PARKINSON’S DISEASE | 0.62 | 904 | 180.80 |
| REICH SG;SAVITT JM | 2019 | PARKINSON’S DISEASE | 3.83 | 137 | 45.67 |
| LAWSON RA;YARNALL AJ;D… | 2016 | COGNITIVE DECLINE AND QUALITY OF LIFE IN INCIDENT PARKINSON’S DISEASE: THE ROLE OF ATTENTION | 4.98 | 99 | 16.50 |
| BAE YJ;KIM J-M;KIM E;L… | 2016 | LOSS OF NIGRAL HYPERINTENSITY ON 3 TESLA MRI OF PARKINSONISM: COMPARISON WITH 123I-FP-CIT SPECT | 6.64 | 73 | 12.17 |
| IRWIN DJ;GROSSMAN M;WE… | 2017 | NEUROPATHOLOGICAL AND GENETIC CORRELATES OF SURVIVAL AND DEMENTIA ONSET IN SYNUCLEINOPATHIES: A RETROSPECTIVE ANALYSIS | 1.93 | 247 | 49.40 |
| Research Area 2: RA 2: protein ubiquitination (n = 1054, density =0.23) | |||||
| SWATEK KN;KOMANDER D | 2016 | UBIQUITIN MODIFICATIONS | 5.51 | 805 | 134.17 |
| YAU R;RAPE M | 2016 | THE INCREASING COMPLEXITY OF THE UBIQUITIN CODE | 6.64 | 510 | 85.00 |
| MEVISSEN TET;KOMANDER D | 2017 | MECHANISMS OF DEUBIQUITINASE SPECIFICITY AND REGULATION | 5.75 | 432 | 86.40 |
| AKUTSU M;DIKIC I;BREMM A | 2016 | UBIQUITIN CHAIN DIVERSITY AT A GLANCE | 8.68 | 257 | 42.83 |
| KWON YT;CIECHANOVER A | 2017 | THE UBIQUITIN CODE IN THE UBIQUITIN-PROTEASOME SYSTEM AND AUTOPHAGY | 6.68 | 312 | 62.40 |
| ZHENG N;SHABEK N | 2017 | UBIQUITIN LIGASES: STRUCTURE, FUNCTION, AND REGULATION | 3.25 | 515 | 103.00 |
| BUETOW L;HUANG DT | 2016 | STRUCTURAL INSIGHTS INTO THE CATALYSIS AND REGULATION OF E3 UBIQUITIN LIGASES | 6.44 | 252 | 42.00 |
| OHTAKE F;SAEKI Y;ISHID… | 2016 | THE K48-K63 BRANCHED UBIQUITIN CHAIN REGULATES NF-ΚB SIGNALING | 9.25 | 155 | 25.83 |
| CLAGUE MJ;URBÉ S;KOMAN… | 2019 | BREAKING THE CHAINS: DEUBIQUITYLATING ENZYME SPECIFICITY BEGETS FUNCTION | 5.44 | 253 | 84.33 |
| OHTAKE F;TSUCHIYA H;SA… | 2018 | K63 UBIQUITYLATION TRIGGERS PROTEASOMAL DEGRADATION BY SEEDING BRANCHED UBIQUITIN CHAINS | 10.00 | 117 | 29.25 |
| Research Area 3: RA 3: single cell analysis (n = 671, density =0.23) | |||||
| SPITZER MH;NOLAN GP | 2016 | MASS CYTOMETRY: SINGLE CELLS, MANY FEATURES | 8.42 | 607 | 101.17 |
| BECHT E;MCINNES L;HEAL… | 2019 | DIMENSIONALITY REDUCTION FOR VISUALIZING SINGLE-CELL DATA USING UMAP | 2.94 | 1214 | 404.67 |
| WOLF FA;ANGERER P;THEI… | 2018 | SCANPY: LARGE-SCALE SINGLE-CELL GENE EXPRESSION DATA ANALYSIS | 2.23 | 1050 | 262.50 |
| CHEVRIER S;LEVINE JH;Z… | 2017 | AN IMMUNE ATLAS OF CLEAR CELL RENAL CELL CARCINOMA | 3.18 | 485 | 97.00 |
| WEI SC;LEVINE JH;COGDI… | 2017 | DISTINCT CELLULAR MECHANISMS UNDERLIE ANTI-CTLA-4 AND ANTI-PD-1 CHECKPOINT BLOCKADE | 2.26 | 643 | 128.60 |
| AZIZI E;CARR AJ;PLITAS… | 2018 | SINGLE-CELL MAP OF DIVERSE IMMUNE PHENOTYPES IN THE BREAST TUMOR MICROENVIRONMENT | 1.69 | 653 | 163.25 |
| SAEYS Y;VAN GASSEN S;L… | 2016 | COMPUTATIONAL FLOW CYTOMETRY: HELPING TO MAKE SENSE OF HIGH-DIMENSIONAL IMMUNOLOGY DATA | 3.92 | 252 | 42.00 |
| WAGNER J;RAPSOMANIKI M… | 2019 | A SINGLE-CELL ATLAS OF THE TUMOR AND IMMUNE ECOSYSTEM OF HUMAN BREAST CANCER | 3.44 | 272 | 90.67 |
| SETTY M;TADMOR MD;REIC… | 2016 | WISHBONE IDENTIFIES BIFURCATING DEVELOPMENTAL TRAJECTORIES FROM SINGLE-CELL DATA | 2.91 | 317 | 52.83 |
| HABER AL;BITON M;ROGEL… | 2017 | A SINGLE-CELL SURVEY OF THE SMALL INTESTINAL EPITHELIUM | 1.39 | 603 | 120.60 |
| Research Area 4: RA 4: T cells in chronice diseases /cancer (n = 491, density =0.27) | |||||
| SIDDIQUI I;SCHAEUBLE K… | 2019 | INTRATUMORAL TCF1 + PD-1 + CD8 + T CELLS WITH STEM-LIKE PROPERTIES PROMOTE TUMOR CONTROL IN RESPONSE TO VACCINATION AND CH… | 1.93 | 435 | 145.00 |
| CASSETTA L;FRAGKOGIANN… | 2019 | HUMAN TUMOR-ASSOCIATED MACROPHAGE AND MONOCYTE TRANSCRIPTIONAL LANDSCAPES REVEAL CANCER-SPECIFIC REPROGRAMMING, BIOMARKERS… | 1.39 | 313 | 104.33 |
| JIA D;LI S;LI D;XUE H;… | 2018 | MINING TCGA DATABASE FOR GENES OF PROGNOSTIC VALUE IN GLIOBLASTOMA MICROENVIRONMENT | 2.06 | 186 | 46.50 |
| HUNDHAUSEN C;ROTH A;WH… | 2016 | ENHANCED T CELL RESPONSES TO IL-6 IN TYPE 1 DIABETES ARE ASSOCIATED WITH EARLY CLINICAL DISEASE AND INCREASED IL-6 RECEPTO… | 3.56 | 57 | 9.50 |
| CHEN L;LU D;SUN K;XU Y… | 2019 | IDENTIFICATION OF BIOMARKERS ASSOCIATED WITH DIAGNOSIS AND PROGNOSIS OF COLORECTAL CANCER PATIENTS BASED ON INTEGRATED BIO… | 3.41 | 58 | 19.33 |
| CHAUDHARY K;POIRION OB… | 2018 | DEEP LEARNING–BASED MULTI-OMICS INTEGRATION ROBUSTLY PREDICTS SURVIVAL IN LIVER CANCER | 0.56 | 347 | 86.75 |
| MAN K;GABRIEL SS;LIAO … | 2017 | TRANSCRIPTION FACTOR IRF4 PROMOTES CD8+ T CELL EXHAUSTION AND LIMITS THE DEVELOPMENT OF MEMORY-LIKE T CELLS DURING CHRONIC… | 1.17 | 166 | 33.20 |
| OMENETTI S;BUSSI C;MET… | 2019 | THE INTESTINE HARBORS FUNCTIONALLY DISTINCT HOMEOSTATIC TISSUE-RESIDENT AND INFLAMMATORY TH17 CELLS | 1.32 | 106 | 35.33 |
| CHEN L;YUAN L;WANG Y;W… | 2017 | CO-EXPRESSION NETWORK ANALYSIS IDENTIFIED FCER1G IN ASSOCIATION WITH PROGRESSION AND PROGNOSIS IN HUMAN CLEAR CELL RENAL C… | 1.93 | 71 | 14.20 |
| MEYER-SCHALLER N;CARDN… | 2019 | A HIERARCHICAL REGULATORY LANDSCAPE DURING THE MULTIPLE STAGES OF EMT | 3.34 | 36 | 12.00 |
| Research Area 5: RA 5: gastrointestinal cancer (n = 369, density =0.65) | |||||
| MEHREN MV;JOENSUU H | 2018 | GASTROINTESTINAL STROMAL TUMORS | 9.83 | 129 | 32.25 |
| JOENSUU H;ERIKSSON M;S… | 2016 | ADJUVANT IMATINIB FOR HIGH-RISK GI STROMAL TUMOR: ANALYSIS OF A RANDOMIZED TRIAL | 8.80 | 135 | 22.50 |
| JOENSUU H;WARDELMANN E… | 2017 | EFFECT OF KIT AND PDGFRA MUTATIONS ON SURVIVAL IN PATIENTS WITH GASTROINTESTINAL STROMAL TUMORS TREATED WITH ADJUVANT IMAT… | 6.98 | 93 | 18.60 |
| BLAY J-Y;SERRANO C;HEI… | 2020 | RIPRETINIB IN PATIENTS WITH ADVANCED GASTROINTESTINAL STROMAL TUMOURS (INVICTUS): A DOUBLE-BLIND, RANDOMISED, PLACEBO-CONT… | 5.20 | 103 | 51.50 |
| NISHIDA T;BLAY J-Y;HIR… | 2016 | THE STANDARD DIAGNOSIS, TREATMENT, AND FOLLOW-UP OF GASTROINTESTINAL STROMAL TUMORS BASED ON GUIDELINES | 2.56 | 209 | 34.83 |
| CASALI PG;FUMAGALLI E;… | 2017 | TEN-YEAR PROGRESSION-FREE AND OVERALL SURVIVAL IN PATIENTS WITH UNRESECTABLE OR METASTATIC GI STROMAL TUMORS: LONG-TERM AN… | 5.35 | 92 | 18.40 |
| RAUT CP;ESPAT NJ;MAKI … | 2018 | EFFICACY AND TOLERABILITY OF 5-YEAR ADJUVANT IMATINIB TREATMENT FOR PATIENTS WITH RESECTED INTERMEDIATE- OR HIGH-RISK PRIM… | 9.00 | 50 | 12.50 |
| HEINRICH MC;JONES RL;V… | 2020 | AVAPRITINIB IN ADVANCED PDGFRA D842V-MUTANT GASTROINTESTINAL STROMAL TUMOUR (NAVIGATOR): A MULTICENTRE, OPEN-LABEL, PHASE … | 4.59 | 90 | 45.00 |
| KOO D-H;RYU M-H;KIM K-… | 2016 | ASIAN CONSENSUS GUIDELINES FOR THE DIAGNOSIS AND MANAGEMENT OF GASTROINTESTINAL STROMAL TUMOR | 4.54 | 90 | 15.00 |
| AKAHOSHI K;OYA M;KOGA … | 2018 | CURRENT CLINICAL MANAGEMENT OF GASTROINTESTINAL STROMAL TUMOR | 4.01 | 98 | 24.50 |
| Research Area 6: RA 6: proteomics analysis (n = 330, density =0.38) | |||||
| PINO LK;SEARLE BC;BOLL… | 2020 | THE SKYLINE ECOSYSTEM: INFORMATICS FOR QUANTITATIVE MASS SPECTROMETRY PROTEOMICS | 2.61 | 193 | 96.50 |
| THE M;MACCOSS MJ;NOBLE… | 2016 | FAST AND ACCURATE PROTEIN FALSE DISCOVERY RATES ON LARGE-SCALE PROTEOMICS DATA SETS WITH PERCOLATOR 3.0 | 3.61 | 130 | 21.67 |
| LANGELLA O;VALOT B;BAL… | 2017 | X!TANDEMPIPELINE: A TOOL TO MANAGE SEQUENCE REDUNDANCY FOR PROTEIN INFERENCE AND PHOSPHOSITE IDENTIFICATION | 4.36 | 100 | 20.00 |
| GEYER PE;HOLDT LM;TEUP… | 2017 | REVISITING BIOMARKER DISCOVERY BY PLASMA PROTEOMICS | 1.34 | 318 | 63.60 |
| GESSULAT S;SCHMIDT T;Z… | 2019 | PROSIT: PROTEOME-WIDE PREDICTION OF PEPTIDE TANDEM MASS SPECTRA BY DEEP LEARNING | 1.11 | 224 | 74.67 |
| GEYER PE;WEWER ALBRECH… | 2016 | PROTEOMICS REVEALS THE EFFECTS OF SUSTAINED WEIGHT LOSS ON THE HUMAN PLASMA PROTEOME | 1.59 | 118 | 19.67 |
| RANDLES MJ;HUMPHRIES M… | 2017 | PROTEOMIC DEFINITIONS OF BASEMENT MEMBRANE COMPOSITION IN HEALTH AND DISEASE | 2.00 | 76 | 15.20 |
| WICHMANN C;MEIER F;WIN… | 2019 | MAXQUANT.LIVE ENABLES GLOBAL TARGETING OF MORE THAN 25,000 PEPTIDES | 3.09 | 47 | 15.67 |
| TSOU C-C;TSAI C-F;TEO … | 2016 | UNTARGETED, SPECTRAL LIBRARY-FREE ANALYSIS OF DATA-INDEPENDENT ACQUISITION PROTEOMICS DATA GENERATED USING ORBITRAP MASS S… | 2.90 | 46 | 7.67 |
| SCHWENK JM;OMENN GS;SU… | 2017 | THE HUMAN PLASMA PROTEOME DRAFT OF 2017: BUILDING ON THE HUMAN PLASMA PEPTIDEATLAS FROM MASS SPECTROMETRY AND COMPLEMENTAR… | 1.21 | 109 | 21.80 |
| Research Area 7: RA 7: data analysis (n = 299, density =3.15) | |||||
| HESTHAVEN JS;UBBIALI S | 2018 | NON-INTRUSIVE REDUCED ORDER MODELING OF NONLINEAR PROBLEMS USING NEURAL NETWORKS | 7.80 | 154 | 38.50 |
| LIEVENS A;JACCHIA S;KA… | 2016 | MEASURING DIGITAL PCR QUALITY: PERFORMANCE PARAMETERS AND THEIR OPTIMIZATION | 10.90 | 74 | 12.33 |
| BANGALORE P;LETZGUS S;… | 2017 | AN ARTIFICIAL NEURAL NETWORK-BASED CONDITION MONITORING METHOD FOR WIND TURBINES, WITH APPLICATION TO THE MONITORING OF TH… | 9.54 | 79 | 15.80 |
| ASKHAM T;KUTZ JN | 2018 | VARIABLE PROJECTION METHODS FOR AN OPTIMIZED DYNAMIC MODE DECOMPOSITION | 8.06 | 73 | 18.25 |
| LAZZARI F;BUFFI A;NEPA… | 2017 | NUMERICAL INVESTIGATION OF AN UWB LOCALIZATION TECHNIQUE FOR UNMANNED AERIAL VEHICLES IN OUTDOOR SCENARIOS | 11.58 | 41 | 8.20 |
| LASSENBERGER A;GRÜNEWA… | 2017 | MONODISPERSE IRON OXIDE NANOPARTICLES BY THERMAL DECOMPOSITION: ELUCIDATING PARTICLE FORMATION BY SECOND-RESOLVED IN SITU … | 7.75 | 60 | 12.00 |
| BARBIERI S;DONATI OF;F… | 2016 | IMPACT OF THE CALCULATION ALGORITHM ON BIEXPONENTIAL FITTING OF DIFFUSION-WEIGHTED MRI IN UPPER ABDOMINAL ORGANS | 7.82 | 58 | 9.67 |
| ROBERT DJ;RAJEEV P;KOD… | 2016 | EQUATION TO PREDICT MAXIMUM PIPE STRESS INCORPORATING INTERNAL AND EXTERNAL LOADINGS ON BURIED PIPES | 13.27 | 28 | 4.67 |
| AMIGO JM;DEL OLMO ALVA… | 2016 | STALING OF WHITE WHEAT BREAD CRUMB AND EFFECT OF MALTOGENIC Α-AMYLASES. PART 1: SPATIAL DISTRIBUTION AND KINETIC MODELING … | 9.76 | 38 | 6.33 |
| ARSLAN D;CHONG KE;MIRO… | 2017 | ANGLE-SELECTIVE ALL-DIELECTRIC HUYGENS’ METASURFACES | 9.43 | 39 | 7.80 |
All results are preliminary so far…